Incidence and duration of hepatitis e virus infection in Dutch blood donors

Transfusion

Volumn 56, Issue 3, 2016, Pages 722-728

  Hogema, Boris M ^a,b   Molier, Michel ^a   Sjerps, Margret ^b   De Waal, Mirjam ^b   Van Swieten, Peter ^b   Van De Laar, Thijs ^a,b   Molenaar De Backer, Marijke ^a,b   Zaaijer, Hans L ^a,c  

^a SANQUIN RESEARCH   (Netherlands)

^b Sanquin Diagnostic Services   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DISEASE DURATION; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INCIDENCE; NETHERLANDS; NONHUMAN; SCREENING; VIRUS LOAD; CLASSIFICATION; FEMALE; GENETICS; MALE; PATHOLOGY; PHYLOGENY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA;

BLOOD DONORS; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INCIDENCE; MALE; NETHERLANDS; PHYLOGENY; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 84960365333     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13402     Document Type: Article

References (18)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al., Hepatitis E. Lancet 2012; 379: 2477-88.
2. Slot E, Hogema BM, Riezebos-Brilman A, et al., Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013; 18:20550.
3. Matsubayashi K, Nagaoka Y, Sakata H, et al., Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44: 934-40.
4. Colson P, Coze C, Gallian P, et al., Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13: 648-9.
5. Hewitt PE, Ijaz S, Brailsford SR, et al., Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384: 1766-73.
6. Andonov A, Rock G, Lin L, et al., Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014; 107: 213-9.
7. Koot H, Hogema BM, Koot M, et al., Frequent hepatitis E in the Netherlands without traveling or immunosuppression. J Clin Virol 2015; 62: 38-40.
8. Fischer C, Hofmann M, Danzer M, et al., Seroprevalence and incidence of hepatitis E in blood donors in upper Austria. PLoS One 2015; 10: e0119576.
9. Gallian P, Lhomme S, Piquet Y, et al., Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 2014; 20: 1914-7.
10. Sauleda S, Ong E, Bes M, et al., Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015; 55: 972-9.
11. Vollmer T, Diekmann J, Johne R, et al., Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012; 50: 2708-13.
12. Statistics Netherlands, Statline database. Agriculture; crops, animals and land by region [Internet] The Hague: Central Statistical Office; 2015 Feb 24 [cited 2015 May 27]. Available from: http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=80780NED&D1=500-517,538,542,550&D2=0&D3=0,5,%28l-2%29,%28l-1%29,l&HDR=G1,G2&STB=T&VW=T.
13. Rutjes SA, Lodder WJ, Bouwknegt M, et al., Increased hepatitis E virus prevalence on Dutch pig farms from 33 to 55% by using appropriate internal quality controls for RT-PCR. J Virol Methods 2007; 143: 112-6.
14. Rutjes SA, Bouwknegt M, van der Giessen JW, et al., Seroprevalence of hepatitis E virus in pigs from different farming systems in the Netherlands. J Food Prot 2014; 77: 640-2.
15. Hogema BM, Molier M, Slot E, et al., Past and present of hepatitis E in the Netherlands. Transfusion 2014; 54: 3092-6.
16. Ijaz S, Vyse AJ, Morgan D, et al., Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44: 272-6.
17. Holm DK, Moessner BK, Engle RE, et al., Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015; 55: 1662-7.
18. Xu C, Wang RY, Schechterly CA, et al., An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013; 53: 2505-11.